Threshold vs non-threshold carcinogens with examples.

Threshold vs non-threshold carcinogens with examples.

• A. All carcinogens have a threshold.
• B. Genotoxic carcinogens generally have no safe threshold (linear no-threshold risk); non-genotoxic carcinogens typically have a threshold. Examples: genotoxic—aflatoxin B1; non-genotoxic—certain peroxisome proliferators.
• C. Genotoxic carcinogens have a threshold, non-genotoxic do not; example: aflatoxin B1 is non-genotoxic.
• D. There are no examples of carcinogens with thresholds.

Answer: (B)

In carcinogen risk, how dose relates to cancer risk depends on the mechanism. Genotoxic carcinogens damage DNA and cause mutations; because a single DNA-altering event can initiate cancer, the risk is typically treated as proportional to dose even at very low exposures—there is no guaranteed safe threshold. This is the linear no-threshold idea used for many genotoxic agents. Non-genotoxic carcinogens cause cancer through other pathways, such as cytotoxicity followed by regenerative proliferation or receptor-mediated effects. These processes usually require a certain level of exposure to trigger them, so there is a threshold below which no appreciable cancer risk is expected. An example of a genotoxic carcinogen is aflatoxin B1, which forms DNA adducts and mutates key genes, contributing to liver cancer with no safe assumed dose. An example of a non-genotoxic carcinogen is a certain peroxisome proliferator, which can promote cancer via non-DNA-damaging pathways and is typically considered to have a threshold. So the correct concept is that genotoxic carcinogens generally have no safe threshold, while non-genotoxic carcinogens typically have a threshold, with the given examples illustrating that distinction.

In carcinogen risk, how dose relates to cancer risk depends on the mechanism. Genotoxic carcinogens damage DNA and cause mutations; because a single DNA-altering event can initiate cancer, the risk is typically treated as proportional to dose even at very low exposures—there is no guaranteed safe threshold. This is the linear no-threshold idea used for many genotoxic agents.

Non-genotoxic carcinogens cause cancer through other pathways, such as cytotoxicity followed by regenerative proliferation or receptor-mediated effects. These processes usually require a certain level of exposure to trigger them, so there is a threshold below which no appreciable cancer risk is expected.

An example of a genotoxic carcinogen is aflatoxin B1, which forms DNA adducts and mutates key genes, contributing to liver cancer with no safe assumed dose. An example of a non-genotoxic carcinogen is a certain peroxisome proliferator, which can promote cancer via non-DNA-damaging pathways and is typically considered to have a threshold.

So the correct concept is that genotoxic carcinogens generally have no safe threshold, while non-genotoxic carcinogens typically have a threshold, with the given examples illustrating that distinction.